Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lucia Di Nardo
Observed names:
Di Nardo, L,
L Di Nardo,
L Nardo,
L. Di Nardo,
Lucia DI NARDO,
Lucia Di Nardo,
Lucia di Nardo
show all 7
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
University of L'Aquila,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0002-2087-7526
Observed ORCID:
0000-0002-2087-7526
OpenAlex ID:
A5038153493
Understanding the Molecular Genetics of Basal Cell Carcinoma
2017
·
Cristina Pellegrini
, Maria Maturo
, et al.
·
International Journal of Molecular Sciences
·
280
PDF
Familial Melanoma: Diagnostic and Management Implications
2019
·
Mariarita Rossi
, Cristina Pellegrini
, et al.
·
Dermatology Practical & Conceptual
·
132
PDF
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies
2019
·
L. Di Nardo
, C. Pellegrini
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
68
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors
2020
·
Pietro Sollena
, Vasiliki Nikolaou
, et al.
·
Breast Cancer Research and Treatment
·
49
Molecular alterations in basal cell carcinoma subtypes
2021
·
Lucia Di Nardo
, Cristina Pellegrini
, et al.
·
Scientific Reports
·
45
PDF
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry
2021
·
Andrea Chiricozzi
, Marina Talamonti
, et al.
·
Allergy
·
38
PDF
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study
2023
·
Andrea Chiricozzi
, Anna Balato
, et al.
·
Journal of the American Academy of Dermatology
·
33
Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients
2021
·
Andrea Chiricozzi
, Niccolò Gori
, et al.
·
Dermatology
·
26
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma
2020
·
Maria Giovanna Maturo
, Sivaramakrishna Rachakonda
, et al.
·
Scientific Reports
·
26
PDF
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype
2017
·
Cristina Pellegrini
, Lucia Di Nardo
, et al.
·
Journal of Molecular Diagnostics
·
25
PDF
Long‐term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real‐world retrospective study
2024
·
Andrea Chiricozzi
, Niccolò Gori
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
21
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study
2023
·
Andrea Chiricozzi
, Giacomo Dal Bello
, et al.
·
Journal of Dermatological Treatment
·
21
PDF
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases
2019
·
C Pellegrini
, L Cardelli
, et al.
·
Acta Dermato Venereologica
·
21
PDF
Wound closure techniques after wide excision for hidradenitis suppurativa: a systematic review and meta‐analysis
2024
·
Corina Ioana Cucu
, Irina Ciobotariu
, et al.
·
International Journal of Dermatology
·
19
PDF
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients
2021
·
C. Pellegrini
, S. Raimondi
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
16
PDF
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
2023
·
A Chiricozzi
, SM Ferrucci
, et al.
·
Expert Opinion on Biological Therapy
·
13
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation
2018
·
Sara Bassoli
, Cristina Pellegrini
, et al.
·
Melanoma Research
·
13
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study
2023
·
Niccolò Gori
, Alvise Sernicola
, et al.
·
Journal of Dermatological Treatment
·
12
PDF
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series
2024
·
Niccolò Gori
, Elena Ippoliti
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
11
The dynamics of circulating tumour DNA ( ctDNA ) during treatment reflects tumour response in advanced melanoma patients
2023
·
Lucia Di Nardo
, Laura Del Regno
, et al.
·
Experimental Dermatology
·
11
PDF
Melanoma types by in vivo reflectance confocal microscopy correlated with protein and molecular genetic alterations: A pilot study
2019
·
Francesca Beretti
, Laura Bertoni
, et al.
·
Experimental Dermatology
·
10
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study
2024
·
Marco Galluzzo
, Emanuele Trovato
, et al.
·
Journal of Clinical Medicine
·
8
PDF
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled
2024
·
Giulia Coscarella
, Gennaro Marco Falco
, et al.
·
Frontiers in Medicine
·
7
PDF
Pregnancy‐associated melanoma epidemiology: A multicentre European study
2025
·
Maria Kostaki
, Michaela Plaka
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
6
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review
2025
·
Marina Romozzi
, Fabio Zeoli
, et al.
·
Headache The Journal of Head and Face Pain
·
6
PDF
Show more works
View as search
Works count:
62
Citation count:
966
H-index:
15
I10-index:
21
Year
Topic
Type